COMPARATIVE IN VITRO EVALUATION OF DIFFERENT BRANDS OF NIFEDIPINE 20mg RETARD TABLET PRODUCTS MARKETED IN ADDIS ABABA, ETHIOPIA
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2018, Vol 8, Issue 3
Abstract
Nifedipine has been formulated and marketed as extended-release-film coated tablet. A certain degree of success has been achieved in reducing the incidence of adverse effects by the use of slow-release formulations such as nifedipine retard. The aim of the present study was to evaluate the physicochemical quality attributes and in vitro equivalence of six brands of nifedipine retard tablets available in different retail outlets in Addis Ababa, Ethiopia. After constructing the calibration curve, the in vitro drug release studies were carried out using USP type I dissolution apparatus at 100 rpm. The dissolution was done in a medium of 0.1N HCl containing 0.5% sodium lauryl sulfate for 12 hrs. All the tablets met the requirement for tablet weight uniformity. The mean crushing strengths of sample tablets ranged from 49.2 to 111.2 N. All the brands studied released more than 80% within 12 hours which is within the tolerance limit.  However the release profile revealed that five of the brands showed over 15% drug release at 1st hour except product F which released only 14.32%. In conclusion, all the brands of tablets had uniform thickness and good hardness. Despite all the brands could sustained the release for over 12 hours recommended for such formulations, five of them showed higher release in the first hour which may affect their in vivo performance.â€
OPTIMIZATION OF THE RELEASE KINETICS OF DILTIAZEM HYDROCHLORIDE FROM TABLETED MICROSPHERES
Formulation F5, F6, F7 and F8 were selected to make the tablets because of their high percentage release (more than 90%). 500 mg weight of tablets containing 120 mg strength of Diltiazem hydrochloride were prepared from...
DIABETIC RETINOPATHY: IMPORTANCE OF PRIMARY CARE PHYSCIAN IN SCREENING
na
PHARMACEUTICAL STANDARDIZATION OF BALADI MANDURAM
Objective: Baladi Manduram (BM) is one of the most impairment and potent herbo-mineral formulation described in Ayurvedic classics viz., Rasa Kamadhenu and Rasayoga sagara specified for the management of the disease Amla...
NON-IONIC SURFACTANT VESICLES (NIOSOMES) BASED NOVEL OPHTHALMIC FORMULATION OF TIMOLOL MALEATE
The objective of the present work was to develop drug loaded niosomal ophthalmic formulation of timolol maleate (an antiglaucomal drug) for enhanced trans-corneal drug permeation and better ocular bioavailability. Timolo...
Perception on generic drugs among general populace visiting a community pharmacy Jaipur, Rajasthan
Healthcare costs have been leading cause of poverty for many Indians. One of the solutions to this is to advocate generic drugs which are cheaper in comparison to brand name drugs. The government of India had made it man...